Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. scores highest on Anchor (59) and lowest on Price (4). Its PosiPenta is 31.29 out of 100, weaker than most similar companies.
On the Penta Grid this week, Ionis Pharmaceuticals, Inc. is Grid #738 of 837 in the Healthcare sector in United States, and Grid #3,541 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. | 31.29 | 4 | 43 | 34 | 16 | 59 |
| Praxis Precision Medicines, Inc. | 40.95 | 13 | 24 | 62 | 69 | 36 |
| Amneal Pharmaceuticals, Inc. | 61.30 | 14 | 83 | 91 | 50 | 68 |
| PACS Group, Inc. | 62.10 | 33 | 74 | 96 | 50 | 58 |
| Chemed Corporation | 66.89 | 33 | 73 | 91 | 64 | 73 |
| Hims & Hers Health, Inc. | 41.96 | 3 | 75 | 53 | 32 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -12.34 |
| P/B ratio | 16.23 |
EEarnings
| Trailing EPS | ₹-329.61 |
| Forward EPS | ₹-105.35 |
NNitro
| Price | 4067.06 |
| 52-week high | 8215.58 |
| 52-week low | 3985.61 |
| Fall from 52-week high | 50.5% |
TTorque
| Return on equity (ROE) | -105.50% |
| Debt-to-equity | 4.98 |
AAnchor
| Beta (price swings) | 0.38 |
| Market cap | ₹67,588 Cr |
| Insider holding | 0.61% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Ionis Pharmaceuticals, Inc.'s PosiPenta score?
Ionis Pharmaceuticals, Inc.'s PosiPenta is 31.29 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Ionis Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Ionis Pharmaceuticals, Inc. is Grid #738 of 837 in the Healthcare sector in United States, and Grid #3,541 of 4,000 in United States.
Which PosiPenta pillar is strongest for Ionis Pharmaceuticals, Inc.?
Anchor (stability and dividends), with a score of 59 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Ionis Pharmaceuticals, Inc.?
Price (valuation), with a score of 4 out of 100: much weaker than most similar companies.
Has Ionis Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 12.66 points, from 18.63 to 31.29.
PositoAI is for research and education only and is not investment advice.